Search

James M. Hewitt

Examiner (ID: 13022, Phone: (571)272-7084 , Office: P/3679 )

Most Active Art Unit
3679
Art Unit(s)
3679, 3628
Total Applications
1889
Issued Applications
1303
Pending Applications
154
Abandoned Applications
447

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5875276 [patent_doc_number] => 20060166972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator' [patent_app_type] => utility [patent_app_number] => 10/564029 [patent_app_country] => US [patent_app_date] => 2004-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8196 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166972.pdf [firstpage_image] =>[orig_patent_app_number] => 10564029 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564029
Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator Jul 6, 2004 Abandoned
Array ( [id] => 6983921 [patent_doc_number] => 20050153991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Methods of treatment of chronic lymphocytic leukemia using roscovitine' [patent_app_type] => utility [patent_app_number] => 10/881869 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14048 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153991.pdf [firstpage_image] =>[orig_patent_app_number] => 10881869 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/881869
Methods of treatment of chronic lymphocytic leukemia using roscovitine Jun 29, 2004 Abandoned
Array ( [id] => 7276505 [patent_doc_number] => 20040235956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders' [patent_app_type] => new [patent_app_number] => 10/879814 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15568 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235956.pdf [firstpage_image] =>[orig_patent_app_number] => 10879814 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/879814
Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders Jun 27, 2004 Abandoned
Array ( [id] => 7352308 [patent_doc_number] => 20040248971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Use of vitamin e succinate and antiandrogen combination' [patent_app_type] => new [patent_app_number] => 10/484785 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10580 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248971.pdf [firstpage_image] =>[orig_patent_app_number] => 10484785 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/484785
Use of vitamin e succinate and antiandrogen combination Jun 6, 2004 Abandoned
Array ( [id] => 7026688 [patent_doc_number] => 20050020558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics' [patent_app_type] => utility [patent_app_number] => 10/856742 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9414 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020558.pdf [firstpage_image] =>[orig_patent_app_number] => 10856742 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/856742
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics May 26, 2004 Issued
Array ( [id] => 7026687 [patent_doc_number] => 20050020557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors' [patent_app_type] => utility [patent_app_number] => 10/856696 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6693 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020557.pdf [firstpage_image] =>[orig_patent_app_number] => 10856696 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/856696
Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors May 26, 2004 Abandoned
Array ( [id] => 7026620 [patent_doc_number] => 20050020534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites' [patent_app_type] => utility [patent_app_number] => 10/856342 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7027 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020534.pdf [firstpage_image] =>[orig_patent_app_number] => 10856342 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/856342
Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites May 26, 2004 Abandoned
Array ( [id] => 7216229 [patent_doc_number] => 20050054625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors' [patent_app_type] => utility [patent_app_number] => 10/856703 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6461 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054625.pdf [firstpage_image] =>[orig_patent_app_number] => 10856703 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/856703
Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors May 26, 2004 Abandoned
Array ( [id] => 7156050 [patent_doc_number] => 20050026893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants' [patent_app_type] => utility [patent_app_number] => 10/857166 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6241 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026893.pdf [firstpage_image] =>[orig_patent_app_number] => 10857166 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857166
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants May 26, 2004 Abandoned
Array ( [id] => 7026685 [patent_doc_number] => 20050020556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes' [patent_app_type] => utility [patent_app_number] => 10/856344 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7309 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020556.pdf [firstpage_image] =>[orig_patent_app_number] => 10856344 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/856344
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes May 26, 2004 Abandoned
Array ( [id] => 7215807 [patent_doc_number] => 20050054589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics' [patent_app_type] => utility [patent_app_number] => 10/857605 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8430 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054589.pdf [firstpage_image] =>[orig_patent_app_number] => 10857605 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857605
Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics May 26, 2004 Abandoned
Array ( [id] => 7249608 [patent_doc_number] => 20040258692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Method for the treatment of cardiotoxicity induced by antitumor compounds' [patent_app_type] => new [patent_app_number] => 10/495836 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3126 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258692.pdf [firstpage_image] =>[orig_patent_app_number] => 10495836 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/495836
Method for the treatment of cardiotoxicity induced by antitumor compounds May 16, 2004 Abandoned
Array ( [id] => 7347512 [patent_doc_number] => 20040192751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Amino acid composition for ameliorating liver failure' [patent_app_type] => new [patent_app_number] => 10/471850 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5239 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192751.pdf [firstpage_image] =>[orig_patent_app_number] => 10471850 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/471850
Amino acid composition for ameliorating liver failure May 13, 2004 Abandoned
Array ( [id] => 7257370 [patent_doc_number] => 20040259959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Method and pharmaceutical preparation for reducing the activity of cells' [patent_app_type] => new [patent_app_number] => 10/495213 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2864 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259959.pdf [firstpage_image] =>[orig_patent_app_number] => 10495213 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/495213
Method and pharmaceutical preparation for reducing the activity of cells May 11, 2004 Abandoned
Array ( [id] => 7075262 [patent_doc_number] => 20050148530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 10/831620 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 87507 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148530.pdf [firstpage_image] =>[orig_patent_app_number] => 10831620 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/831620
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) Apr 22, 2004 Abandoned
Array ( [id] => 5705835 [patent_doc_number] => 20060194883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Mmp expression inhibitor' [patent_app_type] => utility [patent_app_number] => 10/553434 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3260 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194883.pdf [firstpage_image] =>[orig_patent_app_number] => 10553434 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553434
Mmp expression inhibitor Apr 22, 2004 Abandoned
Array ( [id] => 5889974 [patent_doc_number] => 20060276460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns' [patent_app_type] => utility [patent_app_number] => 10/551395 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2877 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276460.pdf [firstpage_image] =>[orig_patent_app_number] => 10551395 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551395
Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns Apr 22, 2004 Abandoned
Array ( [id] => 7467360 [patent_doc_number] => 20040198837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Treatment of neuropathic pain or fibromyalgia' [patent_app_type] => new [patent_app_number] => 10/828607 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2352 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198837.pdf [firstpage_image] =>[orig_patent_app_number] => 10828607 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828607
Treatment of neuropathic pain or fibromyalgia Apr 20, 2004 Abandoned
Array ( [id] => 7190888 [patent_doc_number] => 20040204444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Combination of organic compounds' [patent_app_type] => new [patent_app_number] => 10/826106 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5016 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204444.pdf [firstpage_image] =>[orig_patent_app_number] => 10826106 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/826106
Combination of organic compounds Apr 14, 2004 Abandoned
Array ( [id] => 6959794 [patent_doc_number] => 20050215640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'HMB compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/810762 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19289 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215640.pdf [firstpage_image] =>[orig_patent_app_number] => 10810762 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810762
HMB compositions and uses thereof Mar 25, 2004 Abandoned
Menu